Transmedics Group Inc (NASDAQ: TMDX) is 98.88% higher on its value in year-to-date trading and has touched a low of $55.00 and a high of $177.37 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The TMDX stock was last observed hovering at around $136.20 in the last trading session, with the day’s loss setting it -12.2%.
Currently trading at $124.00, the stock is -6.39% and 11.70% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.09 million and changing -8.96% at the moment leaves the stock 29.28% off its SMA200. TMDX registered -12.68% loss for a year compared to 6-month gain of 92.97%.
The stock witnessed a 1.56% loss in the last 1 month and extending the period to 3 months gives it a 76.31%, and is -13.21% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.27% over the week and 3.07% over the month.
Transmedics Group Inc (TMDX) has around 728 employees, a market worth around $4.20B and $488.23M in sales. Current P/E ratio is 91.14 and Fwd P/E is 48.75. Profit margin for the company is 10.03%. Distance from 52-week low is 125.45% and -30.09% from its 52-week high. The company has generated returns on investments over the last 12 months (6.26%).
The EPS is expected to grow by 81.96% this year
The shares outstanding are 33.83M, and float is at 32.58M with Short Float at 24.81%.
The top institutional shareholder in the company is FMR LLC with over 4.49 million shares valued at $676.31 million. The investor’s holdings represent 13.5576 of the TMDX Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 2.65 million shares valued at $398.47 million to account for 7.9879 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 2.53 million shares representing 7.6281 and valued at over $380.53 million, while DRIEHAUS CAPITAL MANAGEMENT LLC holds 4.487 of the shares totaling 1.49 million with a market value of $223.83 million.
Transmedics Group Inc (TMDX) Insider Activity
The most recent transaction is an insider sale by Ranganath Anil P.,. SEC filings show that Ranganath Anil P. sold 686 shares of the company’s common stock on Jun 09 ’25 at a price of $139.80 per share for a total of $95903.0. Following the sale, the insider now owns 13955.0 shares.
Transmedics Group Inc disclosed in a document filed with the SEC on May 27 ’25 that Basile Edward M (Director) sold a total of 5,000 shares of the company’s common stock. The trade occurred on May 27 ’25 and was made at $126.45 per share for $0.63 million. Following the transaction, the insider now directly holds 2866.0 shares of the TMDX stock.
Still, SEC filings show that on May 27 ’25, EDWARD BASILE (Director) Proposed Sale 5,000 shares at an average price of $126.45 for $0.63 million. The insider now directly holds shares of Transmedics Group Inc (TMDX).
